Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity
Abstract Background Digoxin is a widely prescribed drug for congestive heart failure and atrial fibrillation. Digoxin has a narrow therapeutic index and toxicity can develop quite easily. Digoxin immune fab (DIF) is an effective treatment for toxicity, however there are limited studies characterizin...
Saved in:
Main Authors: | Sophia Sheikh (Author), Taylor Munson (Author), Gerard Garvan (Author), Claire Layton (Author), Dawn Sollee (Author), Colleen Cowdery (Author), Alexa Peterson (Author), Lindsay Schaack Rothstein (Author), Morgan Henson (Author), Hayley Gartner (Author), Michael Ujhelyi (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Digoxin Therapy of Fetal Superior Ventricular Tachycardia: Are Digoxin Serum Levels Reliable?
by: Antonio F. Saad, et al.
Published: (2016) -
MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. F. Zadvorev, et al.
Published: (2018) -
Treatment with Digoxin - is it a clinical challenge? A Retrospective Analysis of Hospitalizations due to Digoxin intoxication
by: Marcin Wais, et al.
Published: (2024) -
A case of Mobitz type II atrioventricular block due to Nerium oleander poisoning successfully managed with digoxin-specific Fab antibody fragments
by: Mustafa Adem Tatlısu, et al.
Published: (2015) -
Suicidal digoxin intoxication in 61 year old patient
by: Erwin Ciechański, et al.
Published: (2019)